Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Pulmozyme for Atelectasis in Mechanically Ventilated Children
2006-002098-30Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of dornase alfa in atelectasis, sponsored by Erasmus MC. Primary endpoint: Change from baseline in chest radiograph-score at 48 hours. Started Jun 2006; status: active.
02
Drugs
dornase alfa
03
Conditions
atelectasis
Beyond the preview
Go deeper on 2006-002098-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002098-30.